Insight

Jun 17, 2025, 08:34

Katsuaki Maehara Shared an Article Published in Signal Transduction and Targeted Therapy on Molecular Pathology and Therapy of NSCLC

Katsuaki Maehara, Director of Medical Education Colleagues, shared on X:

“Advances in molecular pathology and therapy of NSCLC

– Mechanisms involved in cancer cell metastasis in NSCLC

– An algorithm of evidence-based management for stage I-III NSCLC

– Recommended therapy algorithm for oncogene addicted metastatic NSCLC

– Recommended therapy algorithm for non-oncogene addicted metastatic NSCLC

Katsuaki Maehara

– Resistance mechanisms underlying targeted therapy in NSCLC

– Resistance mechanisms underlying immunotherapy in NSCLC

– Established or developing strategies to overcome drug resistance in NSCLC”

Katsuaki Maehara

Title: Advances in molecular pathology and therapy of non-small cell lung cancer

Journal: Signal Transduction and Targeted Therapy

Authors: Qing Huang, Yuanxiang Li, Yingdan Huang, Jingyi Wu, Wendai Bao, Chang Xue, Xiaoyu Li, Shuang Dong, Zhiqiang Dong, Sheng Hu

Read the full text.

Katsuaki Maehara

More posts featuring Katsuaki Maehara on OncoDaily.

cancer Chang Xue immunotherapy Jingyi Wu Katsuaki Maehara non small cell lung cancer NSCLC OncoDaily Oncology Qing Huang Sheng Hu Shuang Dong Signal Transduction and Targeted Therapy targeted therapy Wendai Bao Xiaoyu Li Yingdan Huang Yuanxiang Li Zhiqiang Dong

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine

Smoking and Bladder Cancer: What You Need to Know to Protect Yourself

Cervical Cancer Screening: Who Needs a Pap Smear or HPV Test and When?

Clinical Trials in Cancer Care: What They Are, How to Join, and What to Expect

Linda Evangelista and Breast Cancer: How She Went Against, How She Survived, and More